IMA takes part in ENIAC project DeNeCoR – Devices for NeuroControl and NeuroRehabilitation. The primary aim of DeNeCor is to resolve top issue of increasing the acceptance by neurologists by demonstrating designed co-existency between therapy devices and diagnostic systems. The second aim of DeNeCor is to extrapolate the ‘bilateral’ agreements between AIMD and MRI manufactures in IEC/ISO 10974 to other diagnostic systems.

Focused spatial localization with a transcranial magnetic stimulator (TMS), which requires the design of a coil array with compact distributed power electronic modules and control electronics. Arrays for neural sensing, invasive and non-invasive, based on new sensor arrays and packaging technology, with connection to modulation and rehabilitation devices.

Replacing piezo-electric US transducers by Capacitive Micromachined Ultrasound Transducers (CMUT) including 3D packaging, ASIC development and integration in an endoscopic system. The third aim of DeNeCor is to develop test methods such that the development of therapy devices and diagnostic systems can be decoupled which increases the efficiency of the demonstrator developments and enables technical evolution of all systems at their own pace.

IMA is contributing to the innovation of the Technical Specification IEC/ISO 10974, to the developement of Coexistency Test Setup for clinical demonstration and validation. IMA leads the task of exploitation of the DeNeCoR project.

Project has 23 partners – from Spain, Italy, Austria, Netherlands, Germany, United Kingdom and Czech Republic.